UCSD's Gary Firestein Receives Jane Wyman Humanitarian Award

 

October 25, 2010  |  

Gary S. Firestein, MD, professor of medicine, dean and associate vice chancellor of Translational Medicine and director of the Clinical and Translational Research Institute at the University of California, San Diego School of Medicine, has been named the 2010 recipient of the prestigious Jane Wyman Humanitarian Award. This award recognizes Firestein’s “affiliation with the Arthritis Foundation and its mission, and his extraordinary leadership in rheumatology and philanthropy in the community. “


Gary S. Firestein

The award will be presented at the foundation’s Commitment to a Cure Gala at the Beverly Wilshire Hotel in Beverly Hills on November 1.  Past recipients of the Jane Wyman Humanitarian Award have included Victoria Principal; Sarah Purcell; Kathy Ireland; William Friedkin, Academy Award winning director of “The French Connection” and “The Exorcist;”  Los Angeles Dodger Manager, Joe Torre; and Academy Award winning legend, Al Pacino.

Firestein is considered leading expert in the field of rheumatoid arthritis, a disabling and chronic disease affecting some 2.1 million Americans. His research focuses on the pathogenesis of rheumatoid arthritis and mechanisms of inflammation and his studies have played a pivotal role in the development of the highly effective drugs to treat this crippling disease.

# # #

Media Contact:  Debra Kain, ddkain@ucsd.edu, 619-543-6163




Media Contact

Share This Article


Related News

8/13/2019
UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cel ...
8/13/2019
UC San Diego researchers discovered that removing a single enzyme in mice dramatically boosts survival from sepsis, an often fatal over-reaction of the immune system to infection. The finding provides ...
8/8/2019
The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a ...
8/7/2019
In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could a ...



Follow Us